Research
The Department of Homeland Security (DHS) Science and Technology Directorate (S&T) and Department of Transportation (DOT) have initiated the Next Generation 911 (NG911) systems interoperability and compatibility testing process.
The agencies have selected the Critical Infrastructure Resilience... Read More »
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) will lead a phase 2 clinical trial -- ACTIV-2 -- of experimental therapeutics, to see how an antibody-based treatment and others may fare against those with mild to moderate cases of COVID-19.
Mild to moderate, in... Read More »
The American Association for the Advancement of Science (AAAS) maintains researchers have engineered antiviral compounds proven to kill several types of coronaviruses in both cells and mice.
The work has also proven effective against SARS-CoV-2, the virus that causes COVID-19. The compounds... Read More »
Rapid manufacturing and distribution of a COVID-19 vaccine will rank as one of the most challenging U.S. government initiatives ever undertaken, though it can successfully happen with aggressive planning, management, and funding, concludes a newly released report that includes a powerful indictment... Read More »
A study by the International Institute for Applied Systems Analysis (IIASA) examined the effectiveness of government travel bans in Europe on slowing the spread of COVID-19.
The study found that international flight connections played a particularly important role in the early stages of the... Read More »
A team from The University of Texas Medical Branch at Galveston has found a Zika virus mutation that may be responsible for the outbreak that occurred in 2015 and 2016.
Mosquitoes primarily transmit the Zika virus. Because it circulates between mosquitoes and animals/humans, they are prone to... Read More »
The U.S. Department of Defense (DOD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) awarded Johns Hopkins researchers $35 million for clinical trials to test a convalescent blood plasma outpatient treatment to fight COVID-19.
The treatment... Read More »
Inovio, a biotechnology company, revealed that its COVID-19 vaccine candidate, INO-4800, was effective in protecting non-human primates, specifically rhesus macaques, from the virus 13 weeks after the last vaccination.
These results demonstrate that vaccine candidates reduced viral load in... Read More »
Findings from a Government Accountability Office (GAO) analysis requested by a pair of lawmakers determined nuclear weapons modernization costs will be larger than estimated unless programs are scaled or scrapped.
Sens. Dianne Feinstein (D-CA) and Edward J. Markey (D-MA) requested the GAO... Read More »
The Transportation Security Administration (TSA) has initiated new technology at John F. Kennedy International and LaGuardia Airports capable of validating traveler identification and confirming flight information in near real-time.
The TSA said JFK International Airport has 22 credential... Read More »
The National Institutes of Health (NIH) announced last week that it will award $248.7 million worth of contracts to seven biomedical diagnostic companies for new COVID-19 tests capable of increasing the number, type, and availability of tests by millions per week in short order.
With the need... Read More »
Recognizing the threat of both natural and terrorist-directed anthrax, the U.S. Coast Guard recently undertook its first decontamination field test to determine the best method of decontaminating facilities and vessels exposed to the deadly disease.
This was facilitated by the Analysis for... Read More »
As COVID-19 caused deaths in the United States have crossed 150,000, the Center for Health Security has released a report noting policy actions and data reporting needed at all levels of government to effectively turn the tide against the pandemic.
“Unlike many countries in the world, the... Read More »
The Department of Energy (DOE), U.S. Department of Health and Human Services (HHS), and Department of Veterans Affairs (VA) are working together to share health data as well as research and expertise to aid in the fight against COVID-19.
The initiative between these three government agencies is... Read More »
A COVID-19 vaccine candidate -- mRNA-1273 -- produced by Moderna, Inc. and the National Institute of Allergy and Infectious Diseases (NIAID) brought broad immune responses and protection to the upper and lower airways of nonhuman primates, NIAID scientists reported this week.
After two doses of... Read More »
The investment to prevent the spread of infectious disease are well worth it compared to the costs associated with these outbreaks, a new analysis by published in Science by the nonprofit EcoHealth Alliance proclaims.
While zoonotic disease outbreaks like the one that caused the COVID-19... Read More »
Progress on protecting nuclear materials and facilities against theft and sabotage has slowed significantly over the past two years, the Nuclear Threat Initiativeʻs 2020 NTI Nuclear Security Index has found.
The decline in the rate of improvement to national regulatory structures and the global... Read More »
Scientists from the National Institutes of Health (NIH) published a framework in the New England Journal of Medicine this week for efforts to increase the number, quality and type of daily tests for SARS-CoV-2, the virus that causes COVID-19, to 6 million by the end of 2020.
This has taken the... Read More »
The Coalition for Epidemic Preparedness (CEPI) has extended a call for proposals on COVID-19 vaccines until September, pushing for licensure, efficacy and safety in quick order: a timeframe of just 12-18 months.
The coalition is working to guarantee that manufacturing capabilities and capacities... Read More »
CureVac and GlaxoSmithKline plc (GSK) have signed an agreement to work together on the research, development, manufacturing, and marketing of as many as five mRNA-based vaccines and monoclonal antibodies for use against infectious diseases.
By collaborating, CureVac gains access to GSK’s mRNA... Read More »
A coronavirus vaccine developed by Oxford University produced strong immune responses in a phase 1/2 trial of 1,077 people, scientists from the Jenner Institute and Oxford Vaccine Group reported this week, possibly heralding a safe and effective candidate.
The findings of the UK trial, which... Read More »
Several biopharmaceutical companies are working in unprecedented fashion to develop, manufacture and deliver a safe and effective vaccine to combat COVID-19 as soon as is humanly possible.
Executives from five companies developing COVID-19 vaccine candidates — AstraZeneca, Pfizer, Johnson &... Read More »
The U.S. Food and Drug Administration (FDA) reissued an emergency use authorization (EUA) to Quest Diagnostics for its COVID-19 test.
The Quest test is the first COVID-19 diagnostic test to be authorized for use with pooled samples containing up to four individual swab specimens collected under... Read More »
Under an agreement with Pfizer Inc. and BioNTech SE, the United Kingdom will receive 30 million doses of their BNT162 mRNA-based vaccine candidate for SARS-CoV-2, expected to be delivered over the next year.
While the drug -- four vaccine candidates operating under the broader BNT162 category... Read More »
Recently released study findings published in The Lancet Public Health journal has determined contact tracing speed strategies to be essential to slowing COVID-19 transmission.
Contact tracing involves tracking down all of the people who have been in contact with an infected individual so they... Read More »
U.S. Sen. Dianne Feinstein (D-CA) is calling on the Department of Health and Human Services (HHS) and the Environmental Protection Agency (EPA) to develop and implement a COVID-19 wastewater surveillance program.
Testing wastewater has been proven as a successful method to detect viruses and... Read More »
Looking to inform decision making during a pandemic, COVID-Local has created a policy mapping tool and database for communities, giving them a way to measure the effects of their COVID-19-related actions against specific policies.
COVID Analysis and Mapping of Policies is meant to identify... Read More »
Sandia National Laboratories is turning to machine learning to assist COVID-19 researchers in combing through existing coronavirus studies and data.
Through a mix of algorithms, analytics, and data mining, Sandia wants to make it easy for scientists to find the data they need right at their... Read More »
Moderna, Inc. expects to begin a 30,000 participant phase 3 study of its COVID-19 vaccine candidate later this month, following the publication of an interim phase 1 analysis that demonstrated a generally safe and well-tolerated reaction among a small group of healthy adults.
The results,... Read More »
Reps. Frank Pallone, Jr. (D-NJ), Anna Eshoo (D-CA) and Diana DeGette (D-CO) seek answers from the Food and Drug Administration (FDA) on its process to determine the accuracy of COVID-19 diagnostic and serological tests.
“Public health experts have consistently called for increased access to... Read More »
The University of Queensland’s COVID-19 vaccine candidate reached a milestone as the first participants were enrolled in its Phase 1 clinical trial.
The university’s vaccine is the seventh that is part of the portfolio of vaccines funded by the Coalition for Epidemic Preparedness... Read More »
The U.S. Department of Agriculture (USDA) will invest $27.1 million into the purchase of a foot-and-mouth disease (FMD) vaccine for the National Animal Vaccine and Veterinary Countermeasures Bank.
The purchase would give the government the means to respond to outbreaks of the disease among... Read More »
The U.S. Air Force is participating in a program launched by the Department of Defense to collect convalescent plasma from COVID-19 patients to be used as a possible treatment for the virus.
“We plan to collect more than 8,000 units of plasma from individuals who have recovered from... Read More »
Customs and Border Protection (CBP) personnel along the California border with Mexico recently reported that, in June, the agency seized 43,000 pounds of narcotics valued at nearly $92 million.
Officers at the six land ports of entry were able to foil numerous attempts to smuggle 34,685 pounds... Read More »
The Coalition for Epidemic Preparedness Innovations (CEPI) and Sichuan Clover Biopharmaceuticals, Inc. expanded their partnership last week to guarantee the rapid development and manufacturing of the company’s protein-based COVID-19 vaccine candidate.
Known as S-Trimer, the vaccine is based on... Read More »
